Login / Signup
Why a randomized melanoma screening trial is not a good idea.
Jon Anders Halvorsen
M Løberg
P Gjersvik
I Roscher
M B Veierød
T E Robsahm
L T N Nilsen
M Kalager
M Bretthauer
Published in:
The British journal of dermatology (2018)
Keyphrases
</>
phase iii
study protocol
phase ii
clinical trial
skin cancer
randomized controlled trial
open label
double blind